现在位置：百拇书刊 > 更多... > 风湿症杂志 > 2005年.第1期 《风湿症杂志》.2005年.第1期  * Evaluation of clinically relevant changes in patie  * Defining hip pain for population studies  * Contribution of polymorphisms in the apolipoprotei  * Chondroprotective activity of N-acetylglucosamine  * Case number 32: Thiemann’s disease  * Capability for daily activities in old people with  * Patient centred outcomes in osteoarthritis  * Pain and joint mobility explain individual subdime  * Low density of sympathetic nerve fibres and increa  * Is rheumatoid arthritis disappearing?  * Incidence and prevalence of complaints of the neck  * First line treatment of knee osteoarthritis in out  * Up regulated expression of fractalkine/CX3CL1 and  * Standardised work-up programme for fever of unknow  * Prevalence of anti-cyclic citrullinated peptide an  * Prevalence and determinants of one month hand pain  * Prevalence and predictors of fragility fractures i  * When a DMARD fails, should patients switch to sulf  * Validation and patient acceptance of a computer to  * Using patients’ and rheumatologists’ opinions to s  * Association between baseline radiographic damage a  * Assessing competencies in rheumatology  * A multicentre, randomised, double blind, placebo c  * A good response to early DMARD treatment of patien  * Assessing competencies in rheumatology  * A multicentre, randomised, double blind, placebo c  * A good response to early DMARD treatment of patien  * Capability for daily activities in old people with  * Association between baseline radiographic damage a  * Contribution of polymorphisms in the apolipoprotei  * Chondroprotective activity of N-acetylglucosamine  * Case number 32: Thiemann’s disease  * First line treatment of knee osteoarthritis in out  * Evaluation of clinically relevant changes in patie  * Defining hip pain for population studies  * Low density of sympathetic nerve fibres and increa  * Is rheumatoid arthritis disappearing?  * Incidence and prevalence of complaints of the neck  * Prevalence and predictors of fragility fractures i  * Patient centred outcomes in osteoarthritis  * Pain and joint mobility explain individual subdime  * Prevalence of anti-cyclic citrullinated peptide an  * Prevalence and determinants of one month hand pain  * Using patients’ and rheumatologists’ opinions to s  * Up regulated expression of fractalkine/CX3CL1 and  * Standardised work-up programme for fever of unknow  * When a DMARD fails, should patients switch to sulf  * Validation and patient acceptance of a computer to